Riskpilot← Back to searchSign inGet full accessEläinklinikka Katse Oy
OYActiveY-tunnus 3002085-4Possijärvenkatu 1Veterinary activities · NACE 7500Est. 201910 employeeswww.elainklinikkakatse.fi
Revenue 2024
EUR 1,5M
+40% vs 2023
EBITDA margin
27.2%
+189% vs 2023
Equity ratio
72.5%
Financial strength
Net profit 2024
EUR 297K
+232% vs 2023
| Revenue | EUR 1,5M | +40% |
| EBITDA | EUR 410K | +189% |
| Net profit | EUR 297K | +232% |
| Total assets | EUR 742K | +99% |
| Equity | EUR 538K | +106% |
| Employees | 10 | — |
Legal name
Eläinklinikka Katse Oy
Y-tunnus number
3002085-4
Legal form
Osakeyhtiö
NACE code
7500 · Veterinary activities
Founded
22. toukokuuta 2019
Share capital
EUR 2 500
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet, toimitusjohtaja ja toimitusjohtajan sijainen kaksi yhdessä
Company purpose
Yhtiön toimialana on eläinlääkintäpalvelut.
Address
Possijärvenkatu 1
Phone
+3580207856400
Email
info@elainklinikkakatse.fi
Website
www.elainklinikkakatse.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 505 | 535 | 655 | 1 074 | 1 507 |
| Staff expenses | −156 | −169 | −274 | −432 | −571 |
| EBITDA | 160 | 145 | 137 | 142 | 410 |
| Depreciation & amort. | −15 | −21 | −32 | −29 | −35 |
| EBIT | 145 | 124 | 105 | 113 | 374 |
| Net financials | −6 | −5 | −1 | −1 | −3 |
| Profit before tax | 139 | 119 | 104 | 112 | 371 |
| Tax | 20 | 24 | 21 | 23 | 75 |
| Net profit | 118 | 95 | 83 | 89 | 297 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 228 | 242 | 324 | 373 | 742 |
| Equity | 83 | 160 | 230 | 261 | 538 |
| Long-term debt | 43 | 23 | 9 | 0 | 0 |
| Short-term debt | 103 | 60 | 86 | 112 | 204 |
| Total debt | 145 | 83 | 94 | 112 | 204 |
EBITDA margin
27.2%
This company
15.8%
Market median
+72% vs market
20202024
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
20202024
Return on equity
55.2%
This company
18.4%
Market median
+200% vs market
20202024
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20202024
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JI Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (4) | ||
JP Audit | Audit | 2021 – 2025 |
PT Deputy Member | Deputy Member | 2019 – 2025 |
TM Audit | Audit | 2025 – 2026 |
SK Deputy auditor | Deputy auditor | 2021 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairperson | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Eläinklinikka Katse Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juha Pekka Järvisalo | Audit | 0 companies |
| Johanna Inkeri | Chief Executive Officer | 0 companies |
| Pekka Tuomas Vepsä | Deputy Member | 0 companies |
| Tuure Mutikainen | Audit | 0 companies |
| Satu Kaarina Sullanmaa | Deputy auditor | 0 companies |
| Olli Artturi Leikkonen | Board of Directors | 0 companies |
| Juho Mikael Nirkkonen | Board of Directors | 0 companies |
| Risto Sakari Kankaanpää | Chairperson | 0 companies |